- Home
- SELF vs BRNS Comparison
SELF vs BRNS Comparison
Compare SELF & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | BRNS |
|---|---|---|
| Founded | 1983 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 55.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SELF | BRNS |
|---|---|---|
| Price | $5.05 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 49.2K | ★ 69.3K |
| Earning Date | 11-07-2025 | 11-07-2025 |
| Dividend Yield | ★ 5.86% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $12,733,279.00 | N/A |
| Revenue This Year | $1.59 | N/A |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $32.13 | ★ N/A |
| Revenue Growth | 3.36 | ★ 1766.46 |
| 52 Week Low | $4.73 | $0.64 |
| 52 Week High | $5.89 | $2.92 |
Technical Indicators
Market Signals| Indicator | SELF | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 57.28 | 38.31 |
| Support Level | $4.95 | $0.68 |
| Resistance Level | $5.18 | $0.74 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 90.91 | 31.64 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.